Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H23NO3.ClH |
Molecular Weight | 337.841 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C[C@H](COC1=CC=CC=C1)N[C@H](C)[C@@H](O)C2=CC=C(O)C=C2
InChI
InChIKey=QVPSGVSNYPRFAS-BQZDIUEZSA-N
InChI=1S/C18H23NO3.ClH/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15;/h3-11,13-14,18-21H,12H2,1-2H3;1H/t13-,14-,18-;/m1./s1
DescriptionSources: https://www.drugs.com/cdi/isoxsuprine.htmlCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/22893038 | https://www.ncbi.nlm.nih.gov/pubmed/16388203 | https://www.ncbi.nlm.nih.gov/pubmed/11445487 | https://www.ncbi.nlm.nih.gov/pubmed/2874205
Sources: https://www.drugs.com/cdi/isoxsuprine.html
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/22893038 | https://www.ncbi.nlm.nih.gov/pubmed/16388203 | https://www.ncbi.nlm.nih.gov/pubmed/11445487 | https://www.ncbi.nlm.nih.gov/pubmed/2874205
Isoxsuprine (used as isoxsuprine hydrochloride) is a drug used as a vasodilator in humans (under the trade name Duvadilan) and equines. Isoxsuprine is a β2 adrenoreceptor agonist that causes direct relaxation of uterine and vascular smooth muscle via β2 receptors. Isoxsuprine it is used in humans for treatment of premature labor, i.e. a tocolytic, and as a vasodilator for the treatment of cerebral vascular insufficiency, Raynaud's phenomenon, and other conditions. Isoxsuprine may increase the heart rate, cause changes in blood pressure, and irritate the GI tract. It should, therefore, be used with caution if combined with other drugs that affect blood pressure, such as sedatives and anesthetic drugs. Isoxsuprine is most commonly used to treat hoof-related problems in the horse, most commonly for laminitis and navicular disease, as its effects as a vasodilator are thought to increase circulation within the hoof to help counteract the problems associated with these conditions.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Multi-residue analysis of 10 beta2-agonists in animal tissues using gas chromatography-mass spectrometry]. | 2008 Jan |
|
Prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies. | 2008 Jan 23 |
|
Ritodrine and isoxsuprine in management of preterm labor. | 2009 Oct-Dec |
|
Use of N, N-diethyl-p-phenylenediamine sulphate for the spectrophotometric determination of some phenolic and amine drugs. | 2010 Jun |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2874205
Human myometrial strips were obtained from uteri at the time of cesarean section. The tissues were homogenized in 10 volume of buffer containing 10 mM Tris. HC1 0.25 M sucrose, 1 mM EDTA and 3mM MgCk, pH 7.4, using an Ultra-Turrax PRUhomogenizer. The homogenate was passed through four layers of gauze and centrifuged at 600 x g for 10 min at 4 °C to remove unbroken cells and connective tissue. The supernatant was centrifuged twice at 48 000 χ g for 20 min, with washing of the intermediate pellet. The final pellet was resuspended in assay buffer (50 mM Tris. HC1, 3 mM MgCk, pH 7.4). The membrane preparations were stored in liquid nitrogen until used. 100 μΐ aliquots of the membrane fraction were prepared in triplicate and incubated with 6 nM [3H]-DHA and the increasing concentration of the displacing agent (Isoxsuprine) in a final volume of 300 μΐ assay buffer. After incubation for 20 min at 25 °C, 2 ml of icecold buffer were added and immediately filtered over glassfiber filters
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
82033
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | RxNorm | ||
|
73415938
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
3106
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
V74TEQ36CO
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
CHEMBL1197051
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
100000086440
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
DTXSID1045328
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
209-443-6
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
1354003
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
579-56-6
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
DBSALT001553
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
m6555
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
757067
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
C47576
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
V74TEQ36CO
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY | |||
|
SUB02808MIG
Created by
admin on Fri Dec 15 15:01:21 GMT 2023 , Edited by admin on Fri Dec 15 15:01:21 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD